Genetic Engineering and Biotechnology News

Home Authors Posts by Alex Philippidis

Alex Philippidis

Industry, Academic Professionals Offer Advice for President Obama’s Bioeconomy Blueprint

USPTO Tasked with Evaluating Impact of Gene Patents on Second-Opinion Testing

U.S. Lead in Nanotechnology Depends on Growth of FDA and Gov’t Initiatives

Avastin Label Changes Reignites Debate: Is OS or PFS the Better Regulatory Endpoint?

New Genome Center to Bring Sequencing, Bioinformatics Muscle to Big Apple

Amicus Filings in Prometheus v. Mayo Reflect Divide Over Diagnostic Method Patentability

European Biopharma Firms Struggle to Achieve Healthy Growth in Ailing Economy

Biotech Hiring Faces Uncertain Recovery as Pain of Economic Crash Continues to Throb

From Russia with Drugs and Vaccines, as Federation and Big Pharma Drive Partnerships

NIH Funding Plagued by Potential of Continuing Resolution and Sequestration Measures

Majority Sees BiovaxID Gaining Faster Acceptance if Approved Than Provenge

USPTO Effort for Small Businesses Seeking Overseas Patents Draws Interest from Bioindustry

DNA Research

Product and Service Firms Challenged by Uncertain NIH Funding, Polarization of Sequencing

2-to-1 Majority Envisions Personalized Medicine Approach to Autism, ASDs

Federal Circuit Takes Up En Banc Joint Infringement of Method Patents

Implementation of European Court Decision to Ban hESC Patents Depends on National Patent Offices

Science Agencies Stand to Benefit from Congress Riding Minibus as Vehicle for Faster Budget Approval

Congressional Leaders Expect to Give Personalized Medicine Act Another Shot

orange reflective nanotube structure on white

FDA Evaluating Input from Industry on Nanotech Guidance

Retooling SBIR Not That Easy

1 … 161 162 163 164 165 … 167 Page 163 of 167